NARI - Inari Medical, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Irvine,
United States
Type: Equity
NARI price evolution
NARI
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $39.21 | $89.18 | $57.84 | $56.56 |
| Short term investments | $76.86 | $262.11 | $279.7 | $271.88 |
| Net receivables | $70.12 | $69.59 | $63.13 | $55.72 |
| Inventory | $42.9 | $40.23 | $38.98 | $36.5 |
| Total current assets | $235.56 | $469.06 | $444.62 | $425.61 |
| Long term investments | ||||
| Property, plant & equipment | $69.34 | $70.31 | $70.92 | $71.84 |
| Goodwill & intangible assets | $365.22 | |||
| Total noncurrent assets | $438.67 | $79.77 | $80.35 | $80.93 |
| Total investments | $76.86 | $262.11 | $279.7 | $271.88 |
| Total assets | $674.24 | $548.84 | $524.97 | $506.53 |
| Current liabilities | ||||
| Accounts payable | $10.58 | $10.09 | $7.24 | $7.35 |
| Deferred revenue | ||||
| Short long term debt | $1.69 | $1.63 | $1.58 | $1.53 |
| Total current liabilities | $76.34 | $66.07 | $58.24 | $48.34 |
| Long term debt | $30.36 | $30.63 | $31.09 | $31.46 |
| Total noncurrent liabilities | $132.99 | $30.63 | $31.09 | $31.46 |
| Total debt | $32.05 | $32.26 | $32.67 | $32.98 |
| Total liabilities | $209.32 | $96.69 | $89.32 | $79.8 |
| Shareholders' equity | ||||
| Retained earnings | -$48.49 | -$43.82 | -$46.98 | -$49.07 |
| Other shareholder equity | $8.88 | -$1.16 | -$1.18 | -$0.01 |
| Total shareholder equity | $464.91 | $452.14 | $435.64 | $426.74 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $39.21 | $60.22 | $92.75 | $114.62 |
| Short term investments | $76.86 | $266.18 | $83.35 | $49.98 |
| Net receivables | $70.12 | $58.61 | $42.35 | $28.01 |
| Inventory | $42.9 | $32.58 | $21.05 | $10.6 |
| Total current assets | $235.56 | $422.9 | $245.2 | $205.67 |
| Long term investments | $3.98 | |||
| Property, plant & equipment | $69.34 | $72.36 | $61.38 | $7.5 |
| Goodwill & intangible assets | $365.22 | |||
| Total noncurrent assets | $438.67 | $81.25 | $66.34 | $8.42 |
| Total investments | $76.86 | $266.18 | $87.33 | $49.98 |
| Total assets | $674.24 | $504.15 | $311.54 | $214.09 |
| Current liabilities | ||||
| Accounts payable | $10.58 | $7.66 | $6.54 | $3.05 |
| Deferred revenue | ||||
| Short long term debt | $1.69 | $1.31 | $0.8 | |
| Total current liabilities | $76.34 | $56.17 | $42.51 | $13.84 |
| Long term debt | $30.36 | $30.98 | $28.4 | |
| Total noncurrent liabilities | $132.99 | $30.98 | $29.82 | |
| Total debt | $32.05 | $32.29 | $29.21 | |
| Total liabilities | $209.32 | $87.15 | $72.33 | $13.84 |
| Shareholders' equity | ||||
| Retained earnings | -$48.49 | -$46.85 | -$17.58 | -$27.42 |
| Other shareholder equity | $8.88 | $0.85 | -$0.4 | $0 |
| Total shareholder equity | $464.91 | $417 | $239.21 | $200.25 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $132.09 | $126.37 | $119 | $116.17 |
| Cost of revenue | $17.01 | $14.48 | $13.84 | $13.74 |
| Gross Profit | $115.09 | $111.89 | $105.16 | $102.43 |
| Operating activities | ||||
| Research & development | $22.89 | $21.49 | $21.09 | $22.06 |
| Selling, general & administrative | $101.49 | $88.28 | $85.59 | $85.7 |
| Total operating expenses | $124.39 | $109.78 | $106.67 | $107.76 |
| Operating income | -$9.3 | $2.11 | -$1.51 | -$5.34 |
| Income from continuing operations | ||||
| EBIT | -$3.1 | $5.63 | $3.07 | -$1.15 |
| Income tax expense | $1.49 | $2.43 | $0.94 | $1.02 |
| Interest expense | $0.07 | $0.04 | $0.04 | $0.04 |
| Net income | ||||
| Net income | -$4.67 | $3.16 | $2.08 | -$2.22 |
| Income (for common shares) | -$4.67 | $3.16 | $2.08 | -$2.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $493.63 | $383.47 | $276.98 | $139.67 |
| Cost of revenue | $59.07 | $44.51 | $24.76 | $13.11 |
| Gross Profit | $434.56 | $338.96 | $252.23 | $126.56 |
| Operating activities | ||||
| Research & development | $87.53 | $74.22 | $51.02 | $18.4 |
| Selling, general & administrative | $361.06 | $292.84 | $190.37 | $89.75 |
| Total operating expenses | $448.6 | $367.06 | $241.38 | $108.14 |
| Operating income | -$14.03 | -$28.1 | $10.84 | $18.42 |
| Income from continuing operations | ||||
| EBIT | $4.44 | -$25.89 | $10.98 | $14.92 |
| Income tax expense | $5.88 | $3.08 | $0.84 | |
| Interest expense | $0.2 | $0.29 | $0.29 | $1.14 |
| Net income | ||||
| Net income | -$1.64 | -$29.27 | $9.84 | $13.79 |
| Income (for common shares) | -$1.64 | -$29.27 | $9.84 | $13.79 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$4.67 | $3.16 | $2.08 | -$2.22 |
| Operating activities | ||||
| Depreciation | $3.45 | $2.17 | $2.14 | $2.97 |
| Business acquisitions & disposals | -$240.42 | |||
| Stock-based compensation | $9.8 | $9.84 | $10.35 | $10.34 |
| Total cash flows from operations | $12.24 | $15.94 | $9.76 | -$2.01 |
| Investing activities | ||||
| Capital expenditures | -$2.4 | -$1.61 | -$1.23 | -$0.96 |
| Investments | $183.1 | $13.43 | -$4.85 | -$3.08 |
| Total cash flows from investing | -$59.72 | $11.82 | -$6.08 | -$4.04 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.28 | $5.86 | $0.21 | $4.4 |
| Net borrowings | ||||
| Total cash flows from financing | -$2.41 | $3.47 | -$2.35 | $2.47 |
| Effect of exchange rate | -$0.09 | $0.12 | -$0.05 | -$0.07 |
| Change in cash and equivalents | -$49.97 | $31.34 | $1.27 | -$3.66 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$1.64 | -$29.27 | $9.84 | $13.79 |
| Operating activities | ||||
| Depreciation | $10.73 | $7.12 | $4.31 | $1.39 |
| Business acquisitions & disposals | -$240.42 | |||
| Stock-based compensation | $40.34 | $28.67 | $25.45 | $3.52 |
| Total cash flows from operations | $35.93 | -$13.97 | $25.49 | $1.91 |
| Investing activities | ||||
| Capital expenditures | -$6.2 | -$9.95 | -$13.64 | -$5.46 |
| Investments | $188.6 | -$185.26 | -$37.38 | -$49.98 |
| Total cash flows from investing | -$58.02 | -$195.22 | -$51.02 | -$55.44 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $10.74 | $183.63 | $6.43 | $164.83 |
| Net borrowings | -$20.25 | |||
| Total cash flows from financing | $1.17 | $177.14 | $4.07 | $144.12 |
| Effect of exchange rate | -$0.09 | -$0.48 | -$0.4 | |
| Change in cash and equivalents | -$21.01 | -$32.53 | -$21.86 | $90.59 |
News
Fundamentals
| Market cap | $2.24B |
|---|---|
| Enterprise value | $2.23B |
| Shares outstanding | 57.76M |
| Revenue | $493.63M |
|---|---|
| EBITDA | $15.18M |
| EBIT | $4.44M |
| Net Income | -$1.64M |
| Revenue Q/Q | 22.57% |
| Revenue Y/Y | 28.73% |
| P/E ratio | -1.37K |
|---|---|
| EV/Sales | 4.51 |
| EV/EBITDA | 146.82 |
| EV/EBIT | 501.63 |
| P/S ratio | 4.53 |
| P/B ratio | 4.90 |
| Book/Share | 7.89 |
| Cash/Share | 0.68 |
| EPS | -$0.03 |
|---|---|
| ROA | -0.29% |
| ROE | -0.37% |
| Debt/Equity | 0.45 |
|---|---|
| Net debt/EBITDA | 11.21 |
| Current ratio | 3.09 |
| Quick ratio | 2.52 |